Molecular Mechanisms of Escherichia Coli Pathogenicity

Overview

Journal Nat Rev Microbiol

Specialties Infectious Diseases
Microbiology

Date 2009 Dec 8

PMID 19966814

Citations 456

Authors

Matthew A Croxen

B Brett Finlay

Affiliations

Soon will be listed here.

Abstract

Escherichia coli is a remarkable and diverse organism. This normally harmless commensal needs only to acquire a combination of mobile genetic elements to become a highly adapted pathogen capable of causing a range of diseases, from gastroenteritis to extraintestinal infections of the urinary tract, bloodstream and central nervous system. The worldwide burden of these diseases is staggering, with hundreds of millions of people affected annually. Eight E. coli pathovars have been well characterized, and each uses a large arsenal of virulence factors to subvert host cellular functions to potentiate its virulence. In this Review, we focus on the recent advances in our understanding of the different pathogenic mechanisms that are used by various E. coli pathovars and how they cause disease in humans.

Citing Articles

Low leucine levels in the blood enhance the pathogenicity of neonatal meningitis-causing Escherichia coli.

Sun H, Li X, Yang X, Qin J, Liu Y, Zheng Y Nat Commun. 2025; 16(1):2466.

PMID: 40075077 PMC: 11904087. DOI: 10.1038/s41467-025-57850-2.

Enhancing detection of STEC in the meat industry: insights into virulence of priority STEC.

Tran M, Delannoy S, Fach P Front Microbiol. 2025; 16:1543686.

PMID: 40012779 PMC: 11860885. DOI: 10.3389/fmicb.2025.1543686.

Prevalence of Shiga-Toxigenic in Bovine Manure in the Mid-Atlantic Region of the United States.

Litt P, Omar A, Gartley S, Kelly A, Ramos T, Nyarko E Microorganisms. 2025; 13(2).

PMID: 40005783 PMC: 11858049. DOI: 10.3390/microorganisms13020419.

Multidrug-resistant ESBL in urban surface waters and public health implications: A Case Study from Goranchatbari, Dhaka.

Hossain M, Chowdhury A, Islam M, Kirtunia R, Abedin M, Alam M Heliyon. 2025; 11(3):e42219.

PMID: 39944332 PMC: 11815672. DOI: 10.1016/j.heliyon.2025.e42219.

[Distribution of diarrheagenic pathotypes in the pediatric population and antibiotic susceptibility profile in the Valladolid Oeste health area (ASVAO)].

Martinez-Oliveros Y, Iotti L, Rita-Iotti L, Sanchez B, Eiros J, de Frutos M Rev Esp Quimioter. 2025; 38(2):129-132.

PMID: 39927582 PMC: 11894562. DOI: 10.37201/req/092.2024.

References

Turner S, Scott-Tucker A, Cooper L, Henderson I . Weapons of mass destruction: virulence factors of the global killer enterotoxigenic Escherichia coli. FEMS Microbiol Lett. 2006; 263(1):10-20. DOI: 10.1111/j.1574-6968.2006.00401.x. View

Johnson A, Kaushik R, Francis D, Fleckenstein J, Hardwidge P . Heat-labile enterotoxin promotes Escherichia coli adherence to intestinal epithelial cells. J Bacteriol. 2008; 191(1):178-86. PMC: 2612432. DOI: 10.1128/JB.00822-08. View

Frankel G, Phillips A . Attaching effacing Escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal. Cell Microbiol. 2007; 10(3):549-56. DOI: 10.1111/j.1462-5822.2007.01103.x. View

Justice S, Hung C, Theriot J, Fletcher D, Anderson G, Footer M . Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A. 2004; 101(5):1333-8. PMC: 337053. DOI: 10.1073/pnas.0308125100. View

Sal-Man N, Biemans-Oldehinkel E, Finlay B . Structural microengineers: pathogenic Escherichia coli redesigns the actin cytoskeleton in host cells. Structure. 2009; 17(1):15-9. DOI: 10.1016/j.str.2008.12.001. View

Brest P, Betis F, Cuburu N, Selva E, Herrant M, Servin A . Increased rate of apoptosis and diminished phagocytic ability of human neutrophils infected with Afa/Dr diffusely adhering Escherichia coli strains. Infect Immun. 2004; 72(10):5741-9. PMC: 517549. DOI: 10.1128/IAI.72.10.5741-5749.2004. View

Roy K, Hilliard G, Hamilton D, Luo J, Ostmann M, Fleckenstein J . Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells. Nature. 2008; 457(7229):594-8. PMC: 2646463. DOI: 10.1038/nature07568. View

Samba-Louaka A, Nougayrede J, Watrin C, Jubelin G, Oswald E, Taieb F . Bacterial cyclomodulin Cif blocks the host cell cycle by stabilizing the cyclin-dependent kinase inhibitors p21 and p27. Cell Microbiol. 2008; 10(12):2496-508. DOI: 10.1111/j.1462-5822.2008.01224.x. View

Dhakal B, Mulvey M . Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway. J Biol Chem. 2008; 284(1):446-454. PMC: 2610520. DOI: 10.1074/jbc.M805010200. View

10.

Hodges K, Alto N, Ramaswamy K, Dudeja P, Hecht G . The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity. Cell Microbiol. 2008; 10(8):1735-45. PMC: 2614392. DOI: 10.1111/j.1462-5822.2008.01163.x. View

11.

Weiss S, Ladwein M, Schmidt D, Ehinger J, Lommel S, Stading K . IRSp53 links the enterohemorrhagic E. coli effectors Tir and EspFU for actin pedestal formation. Cell Host Microbe. 2009; 5(3):244-58. DOI: 10.1016/j.chom.2009.02.003. View

12.

Alto N, Weflen A, Rardin M, Yarar D, Lazar C, Tonikian R . The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. J Cell Biol. 2007; 178(7):1265-78. PMC: 2064658. DOI: 10.1083/jcb.200705021. View

13.

Mysorekar I, Isaacson-Schmid M, Walker J, Mills J, Hultgren S . Bone morphogenetic protein 4 signaling regulates epithelial renewal in the urinary tract in response to uropathogenic infection. Cell Host Microbe. 2009; 5(5):463-75. PMC: 2696285. DOI: 10.1016/j.chom.2009.04.005. View

14.

Okuda J, Toyotome T, Kataoka N, Ohno M, Abe H, Shimura Y . Shigella effector IpaH9.8 binds to a splicing factor U2AF(35) to modulate host immune responses. Biochem Biophys Res Commun. 2005; 333(2):531-9. DOI: 10.1016/j.bbrc.2005.05.145. View

15.

Kim J, Thanabalasuriar A, Chaworth-Musters T, Fromme J, Frey E, Lario P . The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function. Cell Host Microbe. 2007; 2(3):160-71. DOI: 10.1016/j.chom.2007.07.010. View

16.

Kenny B, DeVinney R, Stein M, Reinscheid D, Frey E, Finlay B . Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell. 1997; 91(4):511-20. DOI: 10.1016/s0092-8674(00)80437-7. View

17.

Handa Y, Suzuki M, Ohya K, Iwai H, Ishijima N, Koleske A . Shigella IpgB1 promotes bacterial entry through the ELMO-Dock180 machinery. Nat Cell Biol. 2006; 9(1):121-8. DOI: 10.1038/ncb1526. View

18.

Shames S, Auweter S, Finlay B . Co-evolution and exploitation of host cell signaling pathways by bacterial pathogens. Int J Biochem Cell Biol. 2008; 41(2):380-9. DOI: 10.1016/j.biocel.2008.08.013. View

19.

Barnich N, Carvalho F, Glasser A, Darcha C, Jantscheff P, Allez M . CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest. 2007; 117(6):1566-74. PMC: 1868786. DOI: 10.1172/JCI30504. View

20.

Toshima H, Yoshimura A, Arikawa K, Hidaka A, Ogasawara J, Hase A . Enhancement of Shiga toxin production in enterohemorrhagic Escherichia coli serotype O157:H7 by DNase colicins. Appl Environ Microbiol. 2007; 73(23):7582-8. PMC: 2168048. DOI: 10.1128/AEM.01326-07. View